Trial
NCT03377309
Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
American University of Beirut Medical Center
Collaborators
—
Condition
Amyotrophic Lateral Sclerosis
Intervention
Fycompa
Why stopped
Study halted due to adverse events
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-01